Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.95
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.90 (2.022%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 44.95
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Breeding & Genetics Contract Win

12 Jul 2016 07:00

RNS Number : 8661D
Benchmark Holdings PLC
12 July 2016
 

RNS Reach

 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Contract win for Breeding & Genetics division

 

Benchmark Holdings announces that a subsidiary of its Breeding & Genetics division SalmoBreed AS ("SalmoBreed") has signed a ten-year agreement with Lerøy Aakvik Roe and Stamfisk AS ("Lerøy") - one of the world's top three salmon producers - for the supply of the SalmoBreed genetic stem into its production sites. The agreement will see the Lerøy team start breeding with SalmoBreed's genetic lines, producing SalmoBreed strain ova for sale to companies within the Lerøy Group.

 

The agreement will not make a material financial contribution to Benchmark in the short term, however the Directors believe that it is of strategic importance to Benchmark's position in the market. This contract represents an endorsement of SalmoBreed's ability to produce world-class salmon strains, and is an encouraging collaboration with one of the largest producers in the industry.

 

Benchmark's CEO, Malcolm Pye, commented:

 

"We are very pleased to have reached this agreement with such a prominent player in the space, which is testament to the great work being done at SalmoBreed and in our Breeding & Genetics division as a whole. The opportunity to collaborate with Lerøy and have SalmoBreed's genetic lines distributed to its Group establishes SalmoBreed's position as an industry leader."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: +44 (0)1142 409939

Malcolm Pye, CEO

Roland Bonney, COO

Rachel Aninakwah, Communications

Tel: +44 (0)1865 790880

 

Numis

 

Tel: +44 (0)2072 601000

Michael Meade/Freddie Barnfield (NOMAD)

James Black / Tom Ballard (Corporate Broking)

Tavistock

Tel: +44 (0)2079 203150

Matt Ridsdale/Niall Walsh

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRARBMFTMBBBBTF
Date   Source Headline
18th Nov 20207:00 amRNSDirectorate Change
4th Nov 20207:00 amRNSInvestor Presentation for Retail Investors
30th Oct 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNotice of Results
13th Oct 20202:29 pmRNSHolding(s) in Company
12th Oct 20202:50 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Sep 20205:58 pmRNSHolding(s) in Company
10th Sep 20209:15 amRNSPositive Opinion from the EMA on BMK08
4th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSQ3 Results
21st Aug 20207:00 amRNSNotice of Q3 Results
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility
31st Jul 20207:00 amRNSTotal Voting Rights
23rd Jul 202011:05 amRNSSale of vaccine manufacturing assets
1st Jul 20207:00 amRNSSale of FishVet
30th Jun 20207:00 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSSale of Improve International
8th Jun 20204:54 pmRNSDirector/PDMR Shareholding - Replacement
8th Jun 202010:43 amRNSDirector/PDMR Shareholding
5th Jun 20205:50 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSSecond Quarter and Interim Results
27th May 20208:30 amRNSEquity Development Results Webinar
19th May 20207:00 amRNSNotice of Q2 and Interim Results
6th May 202012:09 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights
21st Apr 20207:00 amRNSDirector and Divisional Management Changes
7th Apr 20207:00 amRNSAppointment of Chief Executive Officer
2nd Apr 20207:00 amRNSCovid-19 update
31st Mar 202011:12 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSBlock Listing Six Monthly Review
18th Mar 20207:00 amRNSBlock Admission Application
16th Mar 202012:00 pmRNSDirector Dealings
12th Mar 20201:15 pmRNSResult of AGM
9th Mar 20202:01 pmRNSHolding(s) in Company
9th Mar 20201:46 pmRNSDIRECTOR DEALINGS
28th Feb 20207:00 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSQ1 Results
25th Feb 20209:43 amRNSDIRECTOR SHARE OPTIONS
21st Feb 202010:49 amRNSDirector/PDMR Shareholding
20th Feb 20204:10 pmRNSHolding(s) in Company
20th Feb 20209:15 amRNSHolding(s) in Company
17th Feb 20204:28 pmRNSResult of General Meeting and Total Voting Rights
17th Feb 20207:00 amRNSResult of Open Offer
11th Feb 20207:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
31st Jan 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.